Author: BusinessWire

– IKT-148009 is a mechanistically defined disease-modifying therapy –
ATLANTA–(BUSINESS WIRE)–Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase), a clinical-stage pharmaceutical company developing therapeutics to modify the course of Parkinson…

STAMFORD, Conn.–(BUSINESS WIRE)–Pitney Bowes Inc. (NYSE: PBI), a global technology company that provides commerce solutions in the areas of ecommerce, shipping, mailing and financial services, today announced that the Pitney Bowes Bank has signed a t…

TORONTO–(BUSINESS WIRE)–OBIO® (Ontario Bioscience Innovation Organization) is proud to announce the success of the 2021 OBIO Investment Summit, February 9-10, 2021, which showcased the strength and opportunity in Canada’s health science industry.

Th…

Enhanced data quality, easier workflow, and more versatile analytics using fewer cell numbers
SANTA CLARA, Calif.–(BUSINESS WIRE)–Agilent Technologies Inc. (NYSE: A) today introduced the Agilent Seahorse XF HS Miniplate designed specifically for the…

ALISO VIEJO, Calif.–(BUSINESS WIRE)–Global Genes, a leading rare disease patient advocacy organization, today released NEXT 2021: A Time for Resilience and Ingenuity report, highlighting forward-looking developments, trends, and progress across the r…

MONTPELLIER, France–(BUSINESS WIRE)–#NKcells–EMERCell, a biotechnology company developing immunotherapies and cell-based therapies for oncology targets through to pharmaceutical development, announces the signature of a strategic partnership with On…

VANCOUVER, British Columbia & MONTREAL–(BUSINESS WIRE)–Versant Ventures today announced the filing of an early warning report with respect to the ownership of securities in Repare Therapeutics Inc. (the “Company”) by Versant Venture Capital VI, L.P.,…

VANCOUVER, British Columbia & MONTREAL–(BUSINESS WIRE)–Versant Ventures today announced the filing of an early warning report with respect to the ownership of securities in Repare Therapeutics Inc. (the “Company”) by Versant Venture Capital VI, L.P.,…

ALISO VIEJO, Calif.–(BUSINESS WIRE)–Global Genes, a leading rare disease patient advocacy organization, today released NEXT 2021: A Time for Resilience and Ingenuity report, highlighting forward-looking developments, trends, and progress across the r…

−CDMO with a Six Decades-Long Reputation for Quality and Service Doubles Its Capacity to Take on New Development Projects−
MORTON GROVE, Ill.–(BUSINESS WIRE)–#cdmo–Regis Technologies, Inc. today announced the completion of a major expansion of thei…